Clinical trials
Phase 3 trials in Argentina
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,545 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 6 |
| 2001 | 17 |
| 2002 | 16 |
| 2003 | 39 |
| 2004 | 45 |
| 2005 | 65 |
| 2006 | 117 |
| 2007 | 105 |
| 2008 | 106 |
| 2009 | 94 |
| 2010 | 95 |
| 2011 | 96 |
| 2012 | 90 |
| 2013 | 97 |
| 2014 | 89 |
| 2015 | 91 |
| 2016 | 79 |
| 2017 | 90 |
| 2018 | 122 |
| 2019 | 113 |
| 2020 | 120 |
| 2021 | 135 |
| 2022 | 135 |
| 2023 | 153 |
| 2024 | 158 |
| 2025 | 159 |
| 2026 | 94 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,496 |
| Active, not recruiting | 389 |
| Recruiting | 314 |
| Terminated | 295 |
| Enrolling by invitation | 19 |
| Unknown status | 16 |
| Not yet recruiting | 9 |
| Withdrawn | 6 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 195 |
| AstraZeneca | 177 |
| Hoffmann-La Roche | 164 |
| Eli Lilly and Company | 157 |
| Sanofi | 130 |
| Bristol-Myers Squibb | 120 |
| GlaxoSmithKline | 114 |
| Pfizer | 104 |
| Boehringer Ingelheim | 87 |
| Merck Sharp & Dohme LLC | 87 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 166 |
| Carcinoma, Non-Small-Cell Lung | 119 |
| Breast Neoplasms | 116 |
| Asthma | 82 |
| Arthritis, Rheumatoid | 77 |
| Diabetes Mellitus | 76 |
| Pulmonary Disease, Chronic Obstructive | 71 |
| Obesity | 55 |
| Neoplasm Metastasis | 51 |
| Neoplasms | 50 |
Trials
Showing 1 to 25 of 2,545. Each trial links to its page on Pharma Observatory.
2,445 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.